Alumni Connect: Jonathan L. Myles, MD
Dr. Myles graduated from the Medical College of Ohio in 1983. After completing combined residencies in anatomic and clinical pathology at Cleveland Clinic in 1987, he joined the faculty of the Medical College of Ohio (now University of Toledo Medical Center), where he achieved the rank of associate professor before being recruited back to Cleveland Clinic in 1993.
He has served in a variety of roles in the Robert J. Tomsich Pathology & Laboratory Medicine Institute, and currently serves as Director of Quality Assurance and CPT Coding in Anatomic Pathology. Dr. Myles participates in the genitourinary, breast, medical kidney, and cardiovascular pathology subspecialty services at Cleveland Clinic.
Dr. Myles is a national leader in pathology payment policy. He has served as the pathology advisor to the AMA-RUC (American Medical Association Relative Value Update Committee) since 2006. That committee recommends to CMS the relative value units for physician services.
Dr. Myles has served as chair of the Economic Affairs Committee of the College of American Pathologists (CAP) since 2010. He is a member of the CAP Spokespersons Network and has served as faculty at the Engaged Leadership Academy of the CAP. He has served on the Board of Directors of the Academy of Medicine of Cleveland. Dr. Myles has received the CAP’s Public Service Award (the College’s highest honor related to public service) as well as the CAP’s Outstanding Service Award for his many years advocating for pathologists with both private and governmental agencies.
We recently had the opportunity to ask Dr. Myles to reflect on his training at Cleveland Clinic:
“The best things about my training at the Cleveland Clinic were my fellow residents and the staff physicians who trained me. My mentors, such as Drs. Howard S. Levin and Bruce A. Sebek, inspired me to become the best possible pathologist I could and served as role models in my service to our patients. Dr. Robert S. Galen inspired me to use all the resources available to solve a difficult clinical chemistry issue and recognize that as a pathologist I am an integral part of the patient’s healthcare team. Dr. William R. Hart taught me what questions that you need to ask before making a decision.”
“Cleveland Clinic’s residency program is large and that allowed me to learn from others residents, such as Dr. Charles V. Biscotti, who continues to give me guidance as a colleague today. My mentors always inspired me to do my best and encouraged my participation in local and national residency paper competitions.
Our visiting professors made an impression that has lasted throughout my career. I recall Dr. Fathollah K. Mostofi being a visiting a professor and stating two things are needed to diagnose prostate cancer: cytologic atypia and architectural atypia. That one comment has served me for 30 years as an attending physician.”
We asked Dr. Myles why he is active in professional activities outside of his patient care responsibilities at Cleveland Clinic:
“It is important for patient care that pathology maintains its leading role in medicine. The laboratory drives most medical decision-making by our clinical colleagues, and a less than precise diagnosis not only impacts patient treatment, but increases cost to the healthcare system. The viability of our specialty depends on receiving appropriate compensation for our services. I am currently a candidate for the College of American Pathologists Board of Governors. In that role, I want to ensure that future generations of pathologists will have the same opportunities that I have to participate as a member of the healthcare team.”
“For the past six years, I have served as the pathology specialty director to the Alumni Board. The best part of my role has been to re-connect with you, our alumni. We have updated the contact information for all alumni where possible and have instituted the Article of the Week, which strengthens our connection. As a member of the Alumni Board, I have had the opportunity to meet new leaders at Cleveland Clinic as well as interact with old friends. Thank you for your support during my tenure as your representative.”
We would like to thank Dr. Myles for his immense and much appreciated efforts in his role as pathology specialty director to the Alumni Board. He is leaving this role in late 2016, and we wish him all the best in his new endeavors.
We welcome Dr. Christine Booth as she assumes the role of pathology specialty director to the Alumni Board, and we look forward to her service for our alumni.
Comments are closed